在血栓形成的癌肿患者处理中常见的问题是血小板减少原因的鉴别,是否与化疗、肝素或其他药物相关.未来肿瘤学者将有多种新药可供选择,但这些实验新药对癌肿血栓形成的作用尚未十分明了.尽管癌肿患者抗凝治疗有效,但对生存的助益仍有争议.%A frequent issue in the management of cancer patients with thrombosis is thrombocytopenia, whether related to chemotherapy, heparin, or other drugs. The oncologist will have multiple new anticoagulants to choose from in the future, but now, the effect of these experimental agents on cancer thrombosis is unknown. Despite the effectiveness of anticoagulation in cancer patients, survival benefit remains controversial. Given the ongoing clinical questions and new drugs, anticoagulant therapy in patients with cancer promises to have an exciting future.
展开▼
